Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,992.28
(
1.03%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.36
(
2.09%
)
Bitcoin
75,391.43
(
0.73%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 155773

Wednesday, 01/23/2013 9:08:52 PM

Wednesday, January 23, 2013 9:08:52 PM

Post# of 257250
AGN figures whatever Levadex sales they get from PCP’s are a bonus—they will focus on neuros and pain specialists. However, Levadex is probably the closest AGN has come to having a primary care drug, so they are going to construct an enhanced salesforce to detail Levadex and Botox/migraine.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now